Does the media prefer EVH or SDGR?

In the previous week, Schrodinger had 4 more articles in the media than Evolent Health. MarketBeat recorded 5 mentions for Schrodinger and 1 mentions for Evolent Health. Schrodinger's average media sentiment score of 1.18 beat Evolent Health's score of 0.00 indicating that Schrodinger is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Evolent Health 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Schrodinger 3 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer CERT or EVH?

In the previous week, Certara had 2 more articles in the media than Evolent Health. MarketBeat recorded 3 mentions for Certara and 1 mentions for Evolent Health. Certara's average media sentiment score of 0.96 beat Evolent Health's score of 0.00 indicating that Certara is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Certara 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Evolent Health 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Is EVH or GDRX more profitable?

GoodRx has a net margin of 2.07% compared to Evolent Health's net margin of -24.08%. GoodRx's return on equity of 7.22% beat Evolent Health's return on equity. Company Net Margins Return on Equity Return on Assets Evolent Health -24.08% -4.27% -1.06% GoodRx 2.07% 7.22% 2.53%

Does the media refer more to EVH or GDRX?

In the previous week, GoodRx had 4 more articles in the media than Evolent Health. MarketBeat recorded 5 mentions for GoodRx and 1 mentions for Evolent Health. GoodRx's average media sentiment score of 0.97 beat Evolent Health's score of 0.00 indicating that GoodRx is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Evolent Health 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral GoodRx 3 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to EVH or TDOC?

In the previous week, Teladoc Health had 7 more articles in the media than Evolent Health. MarketBeat recorded 8 mentions for Teladoc Health and 1 mentions for Evolent Health. Teladoc Health's average media sentiment score of 0.79 beat Evolent Health's score of 0.00 indicating that Teladoc Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Evolent Health 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Teladoc Health 5 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive

Does the media favor EVH or HSTM?

In the previous week, HealthStream had 1 more articles in the media than Evolent Health. MarketBeat recorded 2 mentions for HealthStream and 1 mentions for Evolent Health. HealthStream's average media sentiment score of 1.76 beat Evolent Health's score of 0.00 indicating that HealthStream is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Evolent Health 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral HealthStream 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Evolent Health (EVH) Competitors

$4.24 -0.09 (-1.97%)

As of 02:42 PM Eastern

Compare

EVH vs. SDGR, CERT, GDRX, TDOC, and HSTM

Should you buy Evolent Health stock or one of its competitors? Evolent Health's main competitors and comparable companies include Schrodinger (SDGR), Certara (CERT), GoodRx (GDRX), Teladoc Health (TDOC), and HealthStream (HSTM). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare technology" industry.

How does Evolent Health compare to Schrodinger?

Evolent Health (NYSE:EVH) and Schrodinger (NASDAQ:SDGR) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their profitability, institutional ownership, valuation, earnings, dividends, media sentiment, risk and analyst recommendations.

Evolent Health has a beta of 0.84, suggesting that its share price is 16% less volatile than the broader market. Comparatively, Schrodinger has a beta of 1.69, suggesting that its share price is 69% more volatile than the broader market.

Evolent Health currently has a consensus target price of $5.96, indicating a potential upside of 40.50%. Schrodinger has a consensus target price of $20.50, indicating a potential upside of 2.02%. Given Evolent Health's stronger consensus rating and higher probable upside, research analysts clearly believe Evolent Health is more favorable than Schrodinger.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Evolent Health	1 Sell rating(s)	4 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.63
Schrodinger	1 Sell rating(s)	3 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.29

79.1% of Schrodinger shares are held by institutional investors. 1.5% of Evolent Health shares are held by company insiders. Comparatively, 10.1% of Schrodinger shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

In the previous week, Schrodinger had 4 more articles in the media than Evolent Health. MarketBeat recorded 5 mentions for Schrodinger and 1 mentions for Evolent Health. Schrodinger's average media sentiment score of 1.18 beat Evolent Health's score of 0.00 indicating that Schrodinger is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Evolent Health	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Schrodinger	3 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Schrodinger has a net margin of -20.98% compared to Evolent Health's net margin of -24.08%. Evolent Health's return on equity of -4.27% beat Schrodinger's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Evolent Health	-24.08%	-4.27%	-1.06%
Schrodinger	-20.98%	-16.37%	-8.19%

Schrodinger has lower revenue, but higher earnings than Evolent Health. Schrodinger is trading at a lower price-to-earnings ratio than Evolent Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Evolent Health	$1.88B	0.26	-$534.51M	-$4.57	N/A
Schrodinger	$255.87M	5.80	-$103.26M	-$0.74	N/A

Summary

Schrodinger beats Evolent Health on 9 of the 16 factors compared between the two stocks.

How does Evolent Health compare to Certara?

Certara (NASDAQ:CERT) and Evolent Health (NYSE:EVH) are both small-cap healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, analyst recommendations, profitability, institutional ownership, valuation, risk, dividends and media sentiment.

Certara has a beta of 1.4, suggesting that its stock price is 40% more volatile than the broader market. Comparatively, Evolent Health has a beta of 0.84, suggesting that its stock price is 16% less volatile than the broader market.

In the previous week, Certara had 2 more articles in the media than Evolent Health. MarketBeat recorded 3 mentions for Certara and 1 mentions for Evolent Health. Certara's average media sentiment score of 0.96 beat Evolent Health's score of 0.00 indicating that Certara is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Certara	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Evolent Health	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Certara has a net margin of -16.75% compared to Evolent Health's net margin of -24.08%. Certara's return on equity of 3.86% beat Evolent Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Certara	-16.75%	3.86%	2.65%
Evolent Health	-24.08%	-4.27%	-1.06%

Certara has higher earnings, but lower revenue than Evolent Health. Certara is trading at a lower price-to-earnings ratio than Evolent Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Certara	$418.84M	2.85	-$1.60M	-$0.45	N/A
Evolent Health	$1.88B	0.26	-$534.51M	-$4.57	N/A

Certara currently has a consensus target price of $8.28, suggesting a potential upside of 5.92%. Evolent Health has a consensus target price of $5.96, suggesting a potential upside of 40.50%. Given Evolent Health's stronger consensus rating and higher probable upside, analysts clearly believe Evolent Health is more favorable than Certara.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Certara	1 Sell rating(s)	5 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.45
Evolent Health	1 Sell rating(s)	4 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.63

74.0% of Certara shares are owned by institutional investors. 1.1% of Certara shares are owned by company insiders. Comparatively, 1.5% of Evolent Health shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Summary

Certara beats Evolent Health on 11 of the 17 factors compared between the two stocks.

How does Evolent Health compare to GoodRx?

Evolent Health (NYSE:EVH) and GoodRx (NASDAQ:GDRX) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, institutional ownership, earnings, valuation, media sentiment, profitability, analyst recommendations and risk.

GoodRx has a net margin of 2.07% compared to Evolent Health's net margin of -24.08%. GoodRx's return on equity of 7.22% beat Evolent Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Evolent Health	-24.08%	-4.27%	-1.06%
GoodRx	2.07%	7.22%	2.53%

Evolent Health has a beta of 0.84, indicating that its stock price is 16% less volatile than the broader market. Comparatively, GoodRx has a beta of 1.59, indicating that its stock price is 59% more volatile than the broader market.

GoodRx has lower revenue, but higher earnings than Evolent Health. Evolent Health is trading at a lower price-to-earnings ratio than GoodRx, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Evolent Health	$1.88B	0.26	-$534.51M	-$4.57	N/A
GoodRx	$796.85M	1.52	$30.44M	$0.04	88.13

Evolent Health currently has a consensus target price of $5.96, indicating a potential upside of 40.50%. GoodRx has a consensus target price of $4.23, indicating a potential upside of 19.92%. Given Evolent Health's stronger consensus rating and higher possible upside, research analysts plainly believe Evolent Health is more favorable than GoodRx.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Evolent Health	1 Sell rating(s)	4 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.63
GoodRx	3 Sell rating(s)	6 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.08

In the previous week, GoodRx had 4 more articles in the media than Evolent Health. MarketBeat recorded 5 mentions for GoodRx and 1 mentions for Evolent Health. GoodRx's average media sentiment score of 0.97 beat Evolent Health's score of 0.00 indicating that GoodRx is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Evolent Health	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
GoodRx	3 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

63.8% of GoodRx shares are held by institutional investors. 1.5% of Evolent Health shares are held by insiders. Comparatively, 5.9% of GoodRx shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Summary

GoodRx beats Evolent Health on 12 of the 16 factors compared between the two stocks.

How does Evolent Health compare to Teladoc Health?

Evolent Health (NYSE:EVH) and Teladoc Health (NYSE:TDOC) are both small-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, institutional ownership, earnings, profitability, analyst recommendations, dividends, valuation and risk.

Evolent Health has a beta of 0.84, indicating that its share price is 16% less volatile than the broader market. Comparatively, Teladoc Health has a beta of 2.12, indicating that its share price is 112% more volatile than the broader market.

In the previous week, Teladoc Health had 7 more articles in the media than Evolent Health. MarketBeat recorded 8 mentions for Teladoc Health and 1 mentions for Evolent Health. Teladoc Health's average media sentiment score of 0.79 beat Evolent Health's score of 0.00 indicating that Teladoc Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Evolent Health	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Teladoc Health	5 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Positive

Teladoc Health has a net margin of -7.13% compared to Evolent Health's net margin of -24.08%. Evolent Health's return on equity of -4.27% beat Teladoc Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Evolent Health	-24.08%	-4.27%	-1.06%
Teladoc Health	-7.13%	-12.15%	-5.83%

76.8% of Teladoc Health shares are held by institutional investors. 1.5% of Evolent Health shares are held by company insiders. Comparatively, 0.7% of Teladoc Health shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Evolent Health presently has a consensus price target of $5.96, indicating a potential upside of 40.50%. Teladoc Health has a consensus price target of $7.54, indicating a potential upside of 19.14%. Given Evolent Health's stronger consensus rating and higher probable upside, analysts clearly believe Evolent Health is more favorable than Teladoc Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Evolent Health	1 Sell rating(s)	4 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.63
Teladoc Health	1 Sell rating(s)	10 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.25

Teladoc Health has higher revenue and earnings than Evolent Health. Teladoc Health is trading at a lower price-to-earnings ratio than Evolent Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Evolent Health	$1.88B	0.26	-$534.51M	-$4.57	N/A
Teladoc Health	$2.53B	0.45	-$200.32M	-$0.99	N/A

Summary

Teladoc Health beats Evolent Health on 9 of the 16 factors compared between the two stocks.

How does Evolent Health compare to HealthStream?

Evolent Health (NYSE:EVH) and HealthStream (NASDAQ:HSTM) are both small-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, risk, earnings, valuation, media sentiment, profitability, analyst recommendations and dividends.

Evolent Health currently has a consensus price target of $5.96, indicating a potential upside of 40.50%. HealthStream has a consensus price target of $27.00, indicating a potential downside of 6.29%. Given Evolent Health's stronger consensus rating and higher probable upside, analysts plainly believe Evolent Health is more favorable than HealthStream.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Evolent Health	1 Sell rating(s)	4 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.63
HealthStream	0 Sell rating(s)	3 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Evolent Health has a beta of 0.84, meaning that its share price is 16% less volatile than the broader market. Comparatively, HealthStream has a beta of 0.44, meaning that its share price is 56% less volatile than the broader market.

HealthStream has lower revenue, but higher earnings than Evolent Health. Evolent Health is trading at a lower price-to-earnings ratio than HealthStream, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Evolent Health	$1.88B	0.26	-$534.51M	-$4.57	N/A
HealthStream	$304.06M	2.77	$18.34M	$0.72	40.02

69.6% of HealthStream shares are held by institutional investors. 1.5% of Evolent Health shares are held by insiders. Comparatively, 20.4% of HealthStream shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

In the previous week, HealthStream had 1 more articles in the media than Evolent Health. MarketBeat recorded 2 mentions for HealthStream and 1 mentions for Evolent Health. HealthStream's average media sentiment score of 1.76 beat Evolent Health's score of 0.00 indicating that HealthStream is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Evolent Health	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
HealthStream	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

HealthStream has a net margin of 6.60% compared to Evolent Health's net margin of -24.08%. HealthStream's return on equity of 6.81% beat Evolent Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Evolent Health	-24.08%	-4.27%	-1.06%
HealthStream	6.60%	6.81%	4.64%

Summary

HealthStream beats Evolent Health on 11 of the 16 factors compared between the two stocks.

Get Evolent Health News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding EVH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

EVH vs. The Competition

Export

Metric	Evolent Health	Healthcare Technology Industry	Healthcare Sector	NYSE Exchange
Market Cap	$483.33M	$1.72B	$7.07B	$23.52B
Dividend Yield	N/A	4.68%	2.54%	3.72%
P/E Ratio	-0.94	20.76	271.49	29.17
Price / Sales	0.26	87.51	625.75	21.23
Price / Cash	0.92	31.80	28.92	19.95
Price / Book	1.20	6.09	10.98	4.82
Net Income	-$534.51M	-$18.66M	$3.48B	$1.07B
7 Day Performance	-0.59%	0.49%	0.38%	1.04%
1 Month Performance	7.25%	5.71%	3.44%	-1.14%
1 Year Performance	-56.03%	-15.20%	23.27%	12.64%

Evolent Health Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
EVH Evolent Health	2.673 of 5 stars	$4.24 -2.0%	$5.96 +40.8%	-55.0%	$478.81M	$1.88B	N/A	4,200
SDGR Schrodinger	1.2903 of 5 stars	$19.70 -3.5%	$20.50 +4.1%	+5.0%	$1.51B	$255.87M	N/A	790	Positive News
CERT Certara	2.0871 of 5 stars	$8.35 -0.7%	$8.28 -0.9%	-24.5%	$1.28B	$418.84M	N/A	1,576	Positive News
GDRX GoodRx	4.6236 of 5 stars	$3.53 +0.6%	$4.23 +19.8%	-13.0%	$1.20B	$796.85M	88.27	950
TDOC Teladoc Health	2.9596 of 5 stars	$6.51 +2.4%	$7.54 +15.8%	-19.6%	$1.16B	$2.53B	N/A	5,600

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:EVH) was last updated on 9/8/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Evolent Health (EVH) Competitors

EVH vs. SDGR, CERT, GDRX, TDOC, and HSTM

How does Evolent Health compare to Schrodinger?

Summary

How does Evolent Health compare to Certara?

Summary

How does Evolent Health compare to GoodRx?

Summary

How does Evolent Health compare to Teladoc Health?

Summary

How does Evolent Health compare to HealthStream?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

EVH vs. The Competition

Evolent Health Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Evolent Health (EVH) Competitors

EVH vs. SDGR, CERT, GDRX, TDOC, and HSTM

How does Evolent Health compare to Schrodinger?

Which has more risk & volatility, EVH or SDGR?

Do analysts rate EVH or SDGR?

Do insiders & institutionals believe in EVH or SDGR?

Does the media prefer EVH or SDGR?

Is EVH or SDGR more profitable?

Which has stronger valuation and earnings, EVH or SDGR?

Summary

How does Evolent Health compare to Certara?

Which has more risk and volatility, CERT or EVH?

Does the media prefer CERT or EVH?

Is CERT or EVH more profitable?

Which has higher earnings and valuation, CERT or EVH?

Do analysts rate CERT or EVH?

Do institutionals & insiders hold more shares of CERT or EVH?

Summary

How does Evolent Health compare to GoodRx?

Is EVH or GDRX more profitable?

Which has more risk & volatility, EVH or GDRX?

Which has higher valuation & earnings, EVH or GDRX?

Do analysts rate EVH or GDRX?

Does the media refer more to EVH or GDRX?

Do insiders and institutionals believe in EVH or GDRX?

Summary

How does Evolent Health compare to Teladoc Health?

Which has more risk and volatility, EVH or TDOC?

Does the media refer more to EVH or TDOC?

Is EVH or TDOC more profitable?

Do institutionals & insiders believe in EVH or TDOC?

Do analysts rate EVH or TDOC?

Which has preferable valuation and earnings, EVH or TDOC?

Summary

How does Evolent Health compare to HealthStream?

Do analysts recommend EVH or HSTM?

Which has more risk & volatility, EVH or HSTM?

Which has preferable earnings and valuation, EVH or HSTM?

Do insiders and institutionals have more ownership in EVH or HSTM?

Does the media favor EVH or HSTM?

Is EVH or HSTM more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

EVH vs. The Competition

Evolent Health Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools